CSR News: Vedanta’s Balco Medical Centre has breakthrough in treating rare cancers

Balco Medical Centre (BMC), part of the Vedanta Medical Research Foundation, has achieved a breakthrough in treating patients suffering from rare cancers. BMC’s Surgical Oncology team has successfully performed two HIPEC procedures on patients suffering from Pseudomyxoma peritonei and ovary cancer. Both the patients are successfully recovering post this critical 12-hour long and complex surgery.

HIPEC has proven effective for selected patients with advanced or metastatic cancer of the colon, ovary, and appendix, and for cancers in which treatment options are not currently available or have proven to be unsuccessful. These types of complex procedures, which were earlier limited to metro cities have now been made available for the benefit of cancer patients of across India.

Ajay Kapur, CEO, Vedanta Aluminium, and Power and Group Anchor for Vedanta’s CSR efforts said, “Our continuous effort to deliver state-of-the-art services to the community is once again proven by BALCO Medical Centre’s Surgical Oncology team, who achieved a new medical milestone by performing two successful HIPEC procedures. BMC aims to support the society by providing world-class medical facilities, and achievements like these are testimony to Vedanta’s greater CSR mission of ‘Giving Back’ to the communities.”

Balco Medical Centre, VMRF’s first flagship initiative set up in Naya Raipur, Chhattisgarh, is a 170-bed, state-of-the-art tertiary care oncology facility with more than 45 specialist doctors. It provides affordable yet world-class treatment for one of the most critical diseases. Currently, it is providing treatment to patients not only from Chhattisgarh but also from the adjoining states of Odisha, Madhya Pradesh, Maharashtra, Jharkhand, Bihar and Uttar Pradesh.

Speaking on BMC’s new milestone, S. Venkata Kumar, COO, BMC said “At BMC, our vision is to make a cancer-free society. We are continuously striving to develop BMC as a medical and research establishment which has the potential to provide access to affordable, ultra-modern diagnostic and therapeutic facilities to patients from pan-India and abroad. All efforts are now being made to do path-breaking research in oncology space.”

During the current COVID situation, the hospital has provided all the necessary help and support to the government in combating the pandemic. BMC is the first among the three private hospitals in the region with the capability to test SARS-CoV-2 virus. BMC is the only hospital in the state capable of IgG Antibody testing and extracting Convalescent Plasma from patients recovered from COVID 19 for the treatment of severe or life-threatening COVID-19 patients.

The best hospital infection control practices are being followed so as not to compromise the treatment of cancer patients who are immunocompromised. Prior to cancer treatments, patients are screened for COVID-19. It is a proud achievement for BMC that some patients after treatment of COVID-19, subsequently underwent major cancer surgery and have successfully recovered.

These efforts are in sync with the group’s ‘Vedanta Cares’ CSR programme, which aims to provide compassionate care to COVID patients and is now being acknowledged by every citizen of Chhattisgarh.

Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content